Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Dec 8, 2021

Keywords

ClinConnect Summary

This clinical trial is studying a new treatment using Micro/nanobubbles (MNBs) to help heal both acute (recent) and chronic (long-lasting) wounds. The goal is to see how safe and effective this treatment is for people with various types of wounds, including those from surgery, injuries, burns, and certain ulcers related to conditions like diabetes.

If you're over 18 and have a suitable type of wound, you might be eligible to participate. However, if your wound is infected or involves vital structures like nerves or blood vessels, you wouldn't qualify. Participants in the trial can expect to receive the MNB treatment under careful supervision and will help researchers understand how well this new approach works for healing wounds. The trial is currently looking for volunteers, and all genders are welcome to participate.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • are above the age of 18.
• • have traumatic, surgical, or chronic wounds.
• • have radiotherapy related tissue injury.
• • have thermal, chemical, and/or electrical burn injuries.
• • have pressure ulcers, diabetic foot ulcers, venous ulcers, arterial ulcers, and/or neuropathic skin ulcers.
• • have acute ischemic wounds
• Exclusion Criteria:
• • have infected wounds.
• • have wounds with exposed vital structures such as nerves, arteries, and/or veins.
• • have wounds associated with malignancy.